beta 2 adrenoceptor agonists (Pfizer)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug Namebeta 2 adrenoceptor agonists (Pfizer)

Drug Alias NameUK-503590PF-613322

ClassificationSmall molecules

Mechanisms of ActionBeta-2 adrenergic receptor agonists

TargetsBeta-2 adrenergic receptor

Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsPulmonary Disease, Chronic Obstructive

ATC CodeN/A